Literature DB >> 21899886

Acquisition of the novel ABL kinase domain mutation T315L in a relapsed Philadelphia-positive acute lymphoblastic leukemia patient.

Gee Fung How, Martin C Müller, Lay Cheng Lim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21899886     DOI： 10.1016/j.leukres.2011.08.011

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  1 in total

1.  Novel TKI-resistant BCR-ABL1 gatekeeper residue mutations retain in vitro sensitivity to axitinib.

Authors:  E A Lasater; E S Massi; A Stecula; J Politi; S K Tan; C C Smith; M Gunthorpe; J P Holmes; F Chehab; A Sali; N P Shah
Journal:  Leukemia       Date:  2015-10-29       Impact factor: 11.528
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.